Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis

Clinical trial NCT00772304 · COMPLETED

Trial details

NCT number: NCT00772304
Sponsor: Alcon Research
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Allergic Rhinitis

Start date: 2008-10-01
Primary completion: 2008-11-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.